U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07655284) titled 'STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy' on June 12.

Brief Summary: Radical Cystectomy (RC) remains the gold standard for localized muscle-invasive bladder cancer (MIBC); however, use of ureteral stents at time of surgery remains controversial without level 1 evidence to comment on risks or benefits of their use. RC complications commonly include urinary tract infections (UTIs), pyelonephritis, ureteroileal leakage and stenosis, and can occur with either ileal conduit or orthotopic neobladder diversions. Traditionally, ureteral stents are thought to support anastomotic healing and reduce the risk of anast...